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Abstract The induction of apoptosis by cell cycle regulator
molecules under conditions optimal for exponential growth was
examined in rat pheochromocytoma PC12 cells by overexpres-
sion of cyclins and cyclin-dependent kinases (cdks). By flow
cytometry and by immunofluorescence, only cells overexpressing
cdk4 or cyclin D1 underwent apoptosis, which was not associated
with G1-arrest. Cdk4 kinase activity was significantly higher in
cdk4-, or cyclin D1-expressing cells. Furthermore, induction of
apoptosis by cdk4 was abrogated by co-transfection of p16INK4,
or dominant negative cdk4. These results suggest that upregula-
tion of cdk4 kinase activity is a primary and critical mediator of
apoptosis in PC12 cells under physiological conditions. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The cell cycle is strictly regulated by a complex set of mech-
anisms. The G1^S transition is controlled by the speci¢c in-
teraction of several combinations of G1 cyclins and cyclin-
dependent kinases (cdks)[1,2]. Recently, several proteins that
function as positive regulators of the cell cycle have been
demonstrated to induce apoptosis when overexpressed. These
include cyclin D1, c-myc, E2F1 and human papilloma virus
(HPV) oncoproteins [3^6].
We have been investigating the involvement of cell cycle
regulator molecules in the apoptosis of rat pheochromocyto-
ma PC12 cells and described the following [7] : apoptosis in-
duced by serum withdrawal was accompanied by the upregu-
lation of cdk4 protein expression and kinase activity.
Conversely, constitutive overexpression of cdk4 signi¢cantly
promoted apoptosis induced by serum withdrawal, whereas
overexpression of other cyclins, cdk2 or cdc2 did not [7].
Although these results suggest that cdk4 plays a crucial role
in apoptosis induced by serum withdrawal, the apoptotic
function of cdk4 under more physiological conditions has
not been elucidated.
To further clarify this issue, we examined the potential ef-
fect of cell cycle regulator molecules on cell fate by transient
overexpression of their cDNAs in PC12 cells cultured in the
presence of serum, a condition that closely resembles the
physiological condition.
2. Materials and methods
2.1. Cell lines and plasmids transfection
PC12 cells were grown as described [7]. The cDNAs encoding cy-
clins, cdks and dominant negative cdk4 (cdk4dn) were subcloned into
the pME vector [8,9]. The cdk4dn consists of the inactive mutant
(K35M) with a hemagglutinin (HA) tag fused to the amino-terminus
of the cdk4 [9]. Transient transfection was performed by electropora-
tion as described [10]. For double transfection of cdk4/p16 or cdk4/
cdk4dn, 50 Wg of each cDNA (total 100 Wg) was used. After 24 h of
incubation in the normal culture conditions, bromo-deoxyuridine
(BrdU, Sigma) was added to a ¢nal concentration of 50 WM. At 24,
48, 72, 96 and 120 h after transfection, cells were harvested and used
for further experiments.
2.2. Flow cytometry by £uorescein-activated cell sorter (FACS)
The cells were incubated with primary antibodies at 4‡C for 2 h
followed by £uorescein-isothiocyanate (FITC)-conjugated secondary
antibody and propidium iodide (PI) staining [7]. FITC and PI £uo-
rescence were measured using a FACS £ow cytometer (Becton-Dick-
inson)[7]. To analyze the cells overexpressing introduced cDNA prod-
ucts, the gate was set for the fractions manifesting a signi¢cantly
higher level of FITC £uorescence (between channel 101 and 102)
and the cells in those fractions were collected. For cdk4 kinase assay,
cells in those fractions were recovered by a cell sorter.
2.3. Antibodies
Primary antibodies, cyclins A, E, D1, and cdk2, cdk4 and cdc2 were
used at the dilutions as previously described [7,10,11]. Other antibod-
ies were used at the following dilutions: cyclin B1 (Novocastra),
1:100; p16 (Neomarker), 1:200; HA-probe (Santa Cruz), 1:100 and
anti-BrdU antibody (Takara), 1:100. The secondary antibodies were
FITC-conjugated, or rhodamine-conjugated goat anti-mouse IgG, or
swine anti-rabbit IgG (Jackson Immuno Research Lab.); 1:80 dilu-
tions.
2.4. Immuno£uorescence and morphological observation
Cells were stained with the same primary antibodies used for £ow
cytometry [12]. The specimens were examined and images were cap-
tured by a CCD camera (Photometrics). For tentative evaluation of
protein expression levels by image analysis, semiquanti¢cation of
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FITC intensity was performed by IP-Lab software (Scanalytics). The
values in positively stained cells were measured and expressed as ra-
tios relative to the endogenous levels in vector-transfected cells.
2.5. DNA fragmentation assay
At each time point after transfection, 105 cells were harvested which
overexpressed introduced gene products. DNA was extracted with
extraction bu¡er (10 mM Tris^HCl (pH 7.5), 1 mM EDTA, 0.2%
Triton X-100) as previously described [7] and 10 Wg of DNA was
loaded onto a 2% agarose gel. Independent experiments were per-
formed in duplicate.
2.6. In vitro kinase reactions and densitometric analysis
Cdk4 kinase activity was assayed as previously described by inde-
pendent duplicate experiments [7,10]. Densitometric quanti¢cation of
the data was done using NIH images [13].
3. Results and discussion
Apoptosis was de¢ned by the presence of subdiploid DNA
content, nuclear morphology and internucleosomal DNA
fragmentation [7,14].
Fig. 1. Time-course experiment of £ow cytometric analysis of cdk4
protein overexpression and induction of apoptosis. Cells were trans-
fected with cDNA expressing cdk4 protein and stained with the
anti-cdk4 antibody (left columns) and PI (right columns). Results at
24, 48, 96 and 120 h after transfection are shown. The percentages
of cells in the subdiploid fraction are indicated as M1 in the right
columns.
Fig. 2. Flow cytometric analysis of overexpressed proteins and in-
duction of apoptosis. A: Cells were transfected with empty vector
(top row) or with cDNA expressing cdk4 protein (middle and bot-
tom rows). Cells were stained with the antibody (left columns) and
PI (right columns). Cells overexpressing cdk4 protein were collected
by setting the gate (middle and bottom rows), and the DNA con-
tent of these cells was analyzed (bottom row). B: For the results of
cyclin D1 (top row), cdk2 (middle) and cyclin A (bottom), only the
data obtained by collecting overexpressing cells are shown. The re-
sults from cells overexpressing cyclins B1 and E, and cdc2 were sim-
ilar to those of cdk2 or cyclin A. The percentages of cells in the
subdiploid fraction are indicated as M1 in the right columns.
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3.1. Overexpression of cell cycle regulators and induction of
apoptosis
Cells were transfected with cDNAs encoding cyclins A, B1,
D1 or E, cdk2, cdk4 or cdc2, as well as empty vector and the
presence of subdiploid DNA content was examined by £ow
cytometry. Preliminary experiments revealed that higher e⁄-
ciencies of transfection were obtained by 40^100 Wg of cDNA,
and no clear dose-dependency was observed. For the time-
course experiment, the extent of apoptosis was evaluated by
£ow cytometric analysis at 24, 48, 96 and 120 h of incubation
in the normal culture conditions after transfection. The inten-
sity of the FITC £uorescence varied over time: FITC £uores-
cence was below detectable level until 36 h after transfection,
and these levels were the highest around 90^110 h (Fig. 1).
Again, the levels remarkably decreased after 120 h, although
apoptotic fractions could be continuously detected after 48 h
when cDNA encoding cdk4 or cyclin D1 was introduced (Fig.
1). Thus, transfection was performed using 50 Wg of cDNA
and transfected cells were cultured for 96 h.
In untreated parental and vector-transfected cells, the apo-
ptotic subdiploid fraction was minimal up to 0.8% of total
cells (Fig. 2 and Table 1). In contrast, in cdk4-transfected
cells, the percentage of cells exhibiting subdiploid DNA con-
tent rose to 30.3% (Fig. 2A). When cdk4-overexpressing cells
were separated by gating for high FITC intensity, 85.7% had
subdiploid DNA content. Cells transfected with cyclin D1
exhibited a subdiploid DNA content in 32.5% of total cells
and 80.8% of cyclin D1-overexpressing cells (Fig. 2B). How-
ever, cells transfected with cdk2 or other cDNAs were similar
to vector-transfected cells with regard to DNA content (Fig.
2B). The apoptotic fractions in the total cells, as well as in
cells overexpressing cdk4 or cyclin D1, were higher to a sta-
tistically signi¢cant extent (P6 0.001 and P6 0.0001, respec-
tively) (Table 1).
3.2. Morphological change
To con¢rm whether the observed increase of the subdiploid
fraction was due to apoptosis, we examined the nuclear fea-
tures by immuno£uorescence. No remarkable nuclear mor-
phological changes were observed in either the parental or
vector-transfected cells. In cdk4-transfected cells, intense pos-
itive staining was detected in the nucleus of 7.2% of the cells.
In 100 of cdk4-positive cells, 89% (89/100 cells) exhibited
marked shrinkage and condensation of the nuclear chromatin
(Fig. 3). In cells transfected with cyclin D1, 8.8% showed
Table 1
Apoptotic fractions in £ow cytometry
M1 þ 2 S.D. (%)a M1/gate þ 2 S.D. (%)b
vector 0.84 þ 1.5 ^
cyclin A 1.86 þ 1.8 6.35 þ 1.3
cyclin B1 2.45 þ 1.2 5.35 þ 4.5
cyclin D1 32.5 þ 12.6c 80.8 þ 16.2d
cyclin E 2.33 þ 1.5 7.05 þ 3.2
cdc2 5.20 þ 2.2 8.40 þ 4.4
cdk2 1.26 þ 1.4 7.98 þ 3.8
cdk4 30.3 þ 15.1c 85.7 þ 20.0d
aM1: subdiploid fraction in total cells.
bM1/gate: subdiploid fraction in gated cells.
cSigni¢cantly higher than others: P6 0.001.
dSigni¢cantly higher than others: P6 0.0001.
Fig. 3. Morphological observations of protein-overexpressing cells.
Cells were transfected with pME (‘vector’), cDNA encoding cdk4
(‘cdk4’), cyclin D1 (‘cyc D1’) or cdk2 (‘cdk2’). The cells were
stained by the respective antibodies (‘FITC’, left column) and PI
(right column). Vector-transfected cells were stained with anti-cdk4
antibody. Arrows indicate cells with intense positive staining for the
introduced proteins. Since the results from cells overexpressing cy-
clins A, B1 and E, and cdc2 were similar to those of cdk2, only the
data from cdk2-overexpressing cells are shown.
Fig. 4. DNA fragmentation assay. Agarose gel electrophoresis of
DNA extracted from parental cells (‘PC12’), cells overexpressing cy-
clin D1 (‘cyc D1’), and cdk2 (‘cdk2’) as well as those overexpressing
cdk4 (‘cdk4’) during the time-course experiments. Cells were har-
vested at 96 h or at the indicated times after transfection, and 10
Wg of extracted DNA was electrophoresed.
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intense nuclear staining, and 71% (71/100 cells) of those were
accompanied by nuclear bleb formation, fragmentation, nu-
clear shrinkage, and chromatin condensation (Fig. 3). How-
ever, in cdk2-transfected cells, only 4% (4/100 cells) of cdk2-
overexpressing cells exhibited apoptotic change (Fig. 3). Sim-
ilarly, in cells transfected with other cDNAs, most of the
positively stained cells remained unchanged (data not shown).
These results demonstrate that overexpression of cdk4 or cy-
clin D1 can induce apoptosis even in the presence of serum.
3.3. Internucleosomal DNA fragmentation assay
Next, in an attempt at further con¢rmation of apoptosis,
we examined the occurrence of the internucleosomal DNA
fragmentation characteristic of apoptosis during the time
course. Since the number of cdk4-overexpressing cells was
not so remarkable until 48 h after transfection as shown in
Fig. 1, and enough cells were not recovered by cell sorting, we
analyzed the extracted DNA from the gated cells obtained at
48, 96 and 120 h. As shown in Fig. 4, DNA fragmentation
was observed in cdk4- or cyclin D1-overexpressing cells col-
lected by sorting at any time points and the pattern of DNA
fragmentation in those cells was similar and extensive. How-
ever, DNA extracted from cdk2-overexpressing cells did not
show this internucleosomal fragmentation except for slight gel
smearing (Fig. 4).
3.4. Image analysis of FITC intensity
We next examined a correlation between the expression
levels of the introduced gene products and the occurrence of
apoptosis. FITC intensity in cdk4-transfected cells ranged
from 2.1-fold to 86.4-fold higher than endogenous levels,
and cells displaying an FITC intensity more than 25.7-fold
higher exhibited morphological changes characteristic of apo-
ptosis (Fig. 5). There was a statistically signi¢cant di¡erence
in FITC intensities of cdk4 immuno£uorescence between ap-
optotic and non-apoptotic cells (P6 0.01). The intensity of
cyclin D1 staining ranged from 1.4- to 70.6-fold higher than
endogenous level, and apoptosis was observed in cells display-
ing intensities higher than 8.1-fold (Fig. 5). There was also a
statistically signi¢cant di¡erence in cyclin D1 intensities be-
tween apoptotic and non-apoptotic cell groups (P6 0.005). In
cells transfected with cdk2 and other cDNAs, there were few
apoptotic cells, and FITC intensity of the positively stained
cells did not show clear correlation with apoptosis (Fig. 5).
3.5. Abrogation of cdk4-induced apoptosis by cdk4 inhibitor
protein, p16INK4A and by cdk4dn
To con¢rm that induction of apoptosis was due to the
action of cdk4 and cyclin D1, we co-expressed p16, inhibitor
of cdk4 and cdk6, together with cdk4 [2]. Whereas the total
cell apoptotic fraction of cells transfected with cdk4 alone was
30.3% (Fig. 2A), this fraction signi¢cantly declined to 13.5%
in cells transfected with both cdk4 and p16 (P6 0.001, Fig.
6A and Table 2). When cells were gated for high cdk4 expres-
sion, the apoptotic fraction was 40.8% for cells transfected
with both cdk4 and p16 (Fig. 6A), which is signi¢cantly lower
than the 85.7% apoptosis for cells transfected with cdk4 alone
(P6 0.005, Table 2, Fig. 2A). When gated for high p16 ex-
pression, only 6.5% of cells were found in the apoptotic frac-
tion (Fig. 6A). Conversely, when apoptotic cells were col-
lected, these cells exhibited a low level of p16 expression
(Fig. 6B). Thus, the 40.8% of cells found in the apoptotic
fraction represent those in which p16 expression is not dom-
inant against cdk4.
We next used cdk4dn that speci¢cally inhibits wild-type
cdk4 activity by competing for binding to cyclin D [9]. The
apoptotic fraction in the cdk4/cdk4dn co-transfected cells was
12.9% of total cells, which is signi¢cantly lower than that in
cdk4 alone (P6 0.001) (Figs. 2A and 6C, and Table 2). When
cells were gated for high cdk4 expression, the apoptotic frac-
tion was 36.5% of cdk4-overexpressing cells, which was sig-
ni¢cantly lower (P6 0.005) than that in cdk4 alone (Figs. 2A
and 6C, and Table 2). Gating for cdk4dn-expressing cells
revealed that only 0.6% had a subdiploid DNA content
(Fig. 6C). When the apoptotic cells were separated, those cells
revealed a lower level of cdk4dn expression (Fig. 6D). There-
Fig. 5. Semiquanti¢cation of image analysis. The intensity values of
the FITC signal in stained cells relative to endogenous levels are
shown. All the data in cdk4, cyclin D1 and cdk2 stainings are ex-
pressed as dots. The presumed thresholds of expression at which ap-
optosis is induced are indicated as broken lines. Since the results
from cells overexpressing cyclins A, B1 and E, and cdc2 were simi-
lar to those of cdk2, only the data from cdk2-overexpressing cells
are shown.
Table 2
Apoptotic fractions in co-transfection
M1 þ 2 S.D. (%)a M1/gate þ 2 S.D. (%)b
vector (100 Wg) 5.08 þ 4.4 ^
cdk4/p16 13.5 þ 5.2c
cdk4/gate ^ 40.8 þ 16.3d
p16/gate ^ 6.50 þ 4.9
cdk4/cdk4dn 12.9 þ 4.3c
cdk4/gate ^ 36.5 þ 10.7d
cdk4dn/gate ^ 0.61 þ 1.3
aM1: subdiploid fraction in total cells.
bM1/gate: subdiploid fraction in gated cells.
cSigni¢cantly lower than M1 in cdk4 transfection alone: P6 0.001.
dSigni¢cantly lower than M1 in cdk4 transfection alone: P6 0.005.
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fore, upregulation of cdk4 and cyclin D1 seems to be a cause,
rather than a consequence, of apoptosis in PC12 cells.
3.6. Cdk4 kinase activity
We next examined cdk4 kinase activity by sorting cells with
a higher expression of introduced gene products. Cdk4 kinase
activities in cells overexpressing cyclins A, B1 or E, cdc2 or
cdk2 were similar to those of parental and vector-transfected
cells (Fig. 7A). In cdk4-expressing cells, signi¢cantly higher
cdk4 kinase activity (4.8-fold of parental cells) was present.
In addition, cyclin D1-expressing cells manifested higher cdk4
kinase activity (3.1-fold of parental cells) (Fig. 7A). When the
cells co-transfected with cdk4/p16 after sorting by higher cdk4
expression were examined, cdk4 kinase activity was still high,
2.2-fold of vector-transfected cells, probably due to the mix-
ture of p16-positive and -negative fractions in cdk4-expressing
cells (Fig. 7B). However, when co-transfected cells were sorted
with high p16 expression, kinase activity was as low as 0.3-
fold of control cells. Thus, inhibition of cdk4-induced apopto-
sis correlated with inhibition of cdk4 kinase activity.
3.7. Analysis of G1-arrest by BrdU incorporation
To investigate whether apoptosis induced by cdk4/cyclin D1
is caused by or associated with G1-arrest, the relationship
between apoptosis and BrdU incorporation was analyzed by
immuno£uorescence. In vector-transfected cells, 78% of cells
showed incorporated BrdU (data not shown). When we ana-
lyzed cdk4- or cyclin D1-overexpressing cells, most of which
revealed morphological changes of apoptosis in the nuclei,
88% or 91% of those showed positive reactivity by anti-
Fig. 6. Analysis of cells co-transfected with cdk4/p16INK4A, and cdk4/cdk4dn. Cells were co-transfected with cDNA encoding cdk4 and p16 (A,
B) or with cdk4 and cdk4dn (C, D). Cells overexpressing introduced proteins were collected by setting the gate for cdk4 (A and C, middle
rows), p16 (A, bottom row) or for HA (for cdk4dn, C, bottom row), and the DNA content of the collected cells was analyzed. The percentages
of cells in the subdiploid fraction are indicated as M1 in the right columns. (B, D) Cells in the subdiploid fraction were collected by the gate
for M1, and the FITC intensities of cdk4, p16 and cdk4dn in the collected cells were analyzed.
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BrdU staining, respectively (Fig. 8). Similarly, in cdk2-over-
expressing cells, although they did not show morphological
change of apoptosis, 83% showed BrdU incorporation. In
contrast, in p16-expressing cells, only 17% showed BrdU in-
corporation, suggesting G1-arrest caused by overexpressed
p16 protein (Fig. 8). These results indicate that apoptosis
induced by cdk4/cyclin D1 is not associated with G1-arrest.
Recent reports have shown that the ‘inappropriate’ activa-
tion of cyclins and cdks is a critical event during apoptosis in
neuronal cells [3,7,15]. We previously demonstrated that cy-
clins and cdks di¡er in their abilities to induce apoptosis and
concluded that cdk4 is a critical regulator of apoptosis in
PC12 cells [7]. However, there are several reports implicating
cdc2, cyclins B and E, in the apoptosis of neuronal cells
[15,16]. The reason for these diverse results seems to be that
experiments were performed under non-physiological condi-
tions: (i) the establishment of cell lines constitutively overex-
pressing a potential apoptosis-inducing protein [7], (ii) induc-
tion of apoptosis by various triggers, such as serum
withdrawal [7,15], or exposure to anti-cancer drugs [17^19].
In these cases, it is uncertain whether the upregulations of
cyclin/cdk are primary events directly involved in induction
of apoptosis. In turn, the involvement of cyclins/cdks com-
plexes in apoptosis has been suggested by studies using cdk
inhibitors. For example, £avopiridol and olomoucin provide
long-term rescue of neuronal cells from apoptosis [16,18,19].
However, to our knowledge, the direct e¡ect of cyclins/cdks
on apoptosis has not been clearly demonstrated. Herein, we
examined apoptosis in PC12 cells : (i) cultured in the presence
of serum, (ii) via transient assay and (iii) by speci¢cally ana-
lyzing cells overexpressing the protein of interest by cell sort-
ing. Since the cell properties of PC12 cells and culture con-
ditions have been well characterized, the experimental
conditions used in the present study are relatively close to
physiological conditions [3,7,8,16]. Our results suggest that
upregulation of cdk4 activity plays a causative role in initiat-
ing apoptosis in PC12 cells, probably by directing the cells to
early cell cycle transition, rather than leaving the cell in G1-
arrest, as was observed in the experiment of BrdU incorpo-
ration [3,5^7]. This interpretation is supported by the previous
notion that apoptosis in PC12 could occur at any phase of the
cell cycle [20]. However, these e¡ects seem to be speci¢c for
cdk4 and cyclin D1, since overexpression of the other proteins
did not cause apoptosis, and this apoptosis was inhibited by
simultaneous introduction of p16INK4A, or cdk4dn.
The amount of both endogenous cdk4 and cyclin D1 may
be mutually limiting for formation of active cdk4/cyclin D1
complex, and ectopic expression of cdk4 or cyclin D1 may
drive the formation of active cdk4/cyclin D1 complexes, lead-
ing to the induction of apoptosis. Thus, the cdk4 kinase com-
plex may function in a dose-dependent manner and show the
di¡erential e¡ects on cells : endogenous levels of cdk4/cyclin
D1 are necessary to promote cell proliferation, whereas over-
expression induces apoptosis even under otherwise physiolog-
ical conditions. This idea is supported by the results in image
analysis.
The physiological substrate of cdk4/cyclin D1 is presumed
to be the underphosphorylated, active form of pRB [1,2], a
protein that plays a crucial role in protecting cells from apo-
Fig. 7. Kinase activities associated with cdk4. A: Cdk4-associated
kinase activity in parental cells (‘PC12’) and cells expressing cdk4
(‘PC12+cdk4’), cyclin D1 (‘PC12+cyc D1’), cdk2 (‘PC12+cdk2’),
cdc2 (‘PC12+cdc2’) and cyclin A (‘PC12+cyc A’) is shown. B: Cdk4
kinase activity in co-transfected cells with cDNAs of cdk4 and p16
after sorting cells by anti-cdk4 (cdk4/p16) or anti-p16 (cdk4/p16)
antibodies in relation to parental cells (‘PC12’), vector-transfected
cells (100 Wg, ‘vector’) and cells expressing cdk4 (100 Wg, ‘cdk4’) is
shown. The intensities of the radioactive signals were expressed as
ratios relative to that obtained in parental cells.
Fig. 8. E¡ect of protein overexpression on cell cycle progression.
PC12 cells were transfected with cDNA expressing cdk4, cyclin D1
or p16. At 24 h after transfection, BrdU was added to the medium.
Cells were double-stained with antibodies against respective proteins
(‘FITC’, left columns) and anti-BrdU antibody followed by rhod-
amine-conjugated secondary antibody (‘BrdU’, right columns).
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ptosis [21,22]. Accordingly, ectopic overexpression of cyclin
D1, HPV E7, adenovirus E1A, E2F1, or c-myc, all of which
associate with and/or inactivate pRB, has been shown to in-
duce apoptosis [3^6,23,24]. Our results may also be the result
of increased pRB phosphorylation caused by higher cdk4/cy-
clin D1 kinase activity. However, overexpression of other ma-
jor pRB kinases, cdk2 and cdc2, has not been shown to in-
duce apoptosis in the present study even though introduction
of cdk2 slightly enhanced S-phase entry in the experiment of
BrdU incorporation [1,2,25,26]. One possible explanation may
be that di¡erent pRB kinases phosphorylate di¡erent sites,
with di¡erent functional consequences: pRB phosphorylated
at Ser601, Ser773, Ser780 and Ser795, sites of cdk4 phosphoryla-
tion, may be more e¡ective in inducing downstream molecules
in the apoptotic cascade than pRB phosphorylated by cdk2 or
by cdc2 [27^29]. Finally, the possibility still remains that other
critical regulators of apoptosis exist downstream of cdk4/cy-
clin D1.
In summary, we have demonstrated that overexpression of
cdk4 or cyclin D1 induces apoptosis in PC12 cells in the
presence of serum. Since it may be attributable to inactivation
of pRB, a detailed analysis of the status of pRB and the
cloning of other cdk4 substrates which regulate downstream
death factors are underway in our laboratory.
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